Metraipolis › archive › dc_ba29dce58b18

Femoral head collapse after hip intra-articular corticosteroid injection: An institutional response to improve practice and increase patient safety — Europe PMC PMID:34727125

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34727125
DOI
10.1371/journal.pone.0259242
License (as archived)
CC0-1.0
Archived
2026-11-01T16:00:34.199Z
SHA-256 of the archived text
eda5b42168194d5f552645255a5b5f6b364433bddbd9c67bcef435958abc8996
Stable URL of this page
https://metraipolis.com/documento/dc_ba29dce58b18

How to cite

Femoral head collapse after hip intra-articular corticosteroid injection: An institutional response to improve practice and increase patient safety — Europe PMC PMID:34727125 — Europe PMC (en), https://europepmc.org/article/MED/34727125 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ba29dce58b18 (Metraipolis archive dc_ba29dce58b18, sha256 eda5b42168194d5f552645255a5b5f6b364433bddbd9c67bcef435958abc8996)
BibTeX
@misc{dcba29dce58b18,
  title = {Femoral head collapse after hip intra-articular corticosteroid injection: An institutional response to improve practice and increase patient safety — Europe PMC PMID:34727125},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34727125},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ba29dce58b18; sha256 eda5b42168194d5f552645255a5b5f6b364433bddbd9c67bcef435958abc8996},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34727125. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Introduction: Femoral head collapse (FHC) is a rarely reported complication of hip intra-articular corticosteroid injection (IACSI). Upon observing a high rate of FHC after hip IACSI, we sought to (1) describe how we addressed the problem through a systematic evaluation of clinical data and institutional care practices followed by process improvement efforts; and (2) report our results. Methods: Patients receiving hip IACSI during a 27-month period underwent retrospective review to determine the rate of FHC and to identify associated patient factors or practice shortfalls. Findings led to institution-wide interventions: (1) to improve patient/provider awareness of this association; and (2) to develop/implement practice guidelines. Rates of FHC after hip IACSI and practice patterns among providers before and after intervention were compared. Results: Initial FHC rate after hip IACSI was 20.4%. Patient-related factors included body mass index (p = 0.025), history of cancer therapy (p = 0.012), Vitamin D level (p = 0.030), and multiple injections (p = 0.004). Volume/dose of injectate and post-injection surveillance methods varied widely. Quality improvement (QI) intervention resulted in fewer treatment referrals (from 851 to 436), fewer repeat injections (mean = 1.61 to 1.37; p = 0.0006), and a 5% lower FHC rate (p = 0.1292). Variation in practice patterns persisted, so a systems-based Clinical Pathway was established. Discussion: When a high rate of FHC after hip IACSI was found to be associated with certain patient and practice factors, introduction of education materials and treatment guidelines decreased number of referrals, number of injections per patient, and FHC rate. In the absence of the systems-based Pathway, the type, dose, and volume of injectate and post-procedure follow-up remained variable.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-11-02).
Identificativi: PMID 34727125 · PMCID PMC8562809 · DOI 10.1371/journal.pone.0259242.
Descrittori MeSH principali: Femur Head; Adrenal Cortex Hormones.
Pagina: https://europepmc.org/article/MED/34727125 — https://doi.org/10.1371/journal.pone.0259242. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-01T15:53:31.177Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.